Story of Vitamin D Toxicity (2022)

Original Article ↗ Hacker News Discussion ↗

Prevalence of Deficiency & Typical Supplementation

  • Many commenters report lab-confirmed vitamin D deficiency, especially in high latitudes, winter, indoor workers, and during COVID lockdowns.
  • Common long‑term doses mentioned: 1,000–2,000 IU/day; many take 3,000–5,000 IU/day in winter; some report needing 7,000–12,000 IU/day or even more to reach mid‑normal serum levels.
  • Several say supplementation was “life changing” for fatigue, mood, joint pain, or skin conditions, though others saw little effect.

Debate Over “Safe” Doses and Toxicity

  • One side: toxicity is rare and usually tied to extreme intakes (e.g., ≥50,000–100,000 IU/day for months); fear is “overblown.”
  • Other side: endocrinology-focused clinicians in the thread report seeing multiple toxicity/hypercalcemia cases from 5,000 IU/day taken for years.
  • Anecdotes span the range: some tolerate 5,000–10,000 IU/day for years with normal labs; others develop high calcium or severe symptoms at 5,000 IU/day.

Testing, Individual Variation, and Guidelines

  • Strong theme: inter-individual variability in absorption, metabolism, body fat, genetics, and comorbid disease; dose must be guided by blood tests.
  • Several argue that anything above ~2,000 IU/day long‑term should be paired with periodic 25(OH)D and calcium checks.
  • There’s disagreement over RDAs: some cite work claiming a 10× underestimation and advocate ~4,000–8,000 IU/day; others call this weakly evidenced.

Sunlight vs Oral Vitamin D

  • UVB exposure can generate ~10,000 IU equivalent, but skin synthesis is self‑limiting via photodegradation of precursors; this is contrasted with unregulated oral intake.
  • Commenters note that modern clothing, latitude, and indoor life make relying on sun alone unrealistic for many.

Cofactors: K2, Magnesium, Calcium

  • Repeated suggestions to pair D3 with K2 (for directing calcium to bone) and adequate magnesium (cofactor in D metabolism).
  • Some claims about K2 reducing D absorption are challenged as unsubstantiated in medical research.

Evidence Quality and COVID

  • Thread criticizes overreliance on review articles that loop back to a small number of short, high‑dose studies and controversial advocates.
  • Distinction made between observational associations (e.g., better COVID outcomes with higher D) and randomized trials, where benefits beyond bone health are modest or inconsistent.

OTC Availability, Labeling, and Trust

  • Concern that US pharmacies sell 5,000–10,000 IU pills with “once daily” instructions and little toxicity warning, unlike NSAIDs or acetaminophen.
  • Others defend OTC access, arguing vitamin D risk is low relative to common drugs.
  • Multiple commenters emphasize: supplements can be misdosed or mislabeled; regular labs should trump generic dosage advice.